Literature DB >> 31278893

Exogenous nicotinamide adenine dinucleotide administration alleviates ischemia/reperfusion-induced oxidative injury in isolated rat hearts via Sirt5-SDH-succinate pathway.

Ling Liu1, Qunying Wang1, Bangshu Zhao1, Qian Wu1, Ping Wang2.   

Abstract

The metabolic disorder of succinate in myocardial tissue during ischemia-reperfusion can lead to the myocardial oxidative injury. The activation of succinate dehydrogenase (SDH) plays a vital role in the process. Silent information regulator 5 (Sirt5), a nicotinamide adenine dinucleotide (NAD)-dependent desuccinylase, desuccinylates and inactivates SDH thus exerting a protective effect on the myocardium. This research was designed to investigate whether exogenous NAD protects the myocardium from the ischemia-reperfusion-induced oxidative injury through regulating Sirt5-SDH pathway and succinate metabolism. We first found that myocardial total NAD level was remarkably increased with NAD treatment (10 mg/kg) for 14 days. NAD administration significantly decreased the lactate dehydrogenase (LDH) level in coronary leakage, decreased the malondialdehyde (MDA) level and increased the reduced glutathione/oxidized glutathione disulfide ratio (GSH/GSSG) in myocardial tissue. In addition, NAD treatment effectively attenuated the depression of cardiac function in the isolated rat hearts after ischemia-reperfusion. Furthermore, we found that exogenous NAD attenuated the succinate accumulation during ischemia and decreased its depleting rate during reperfusion. We also found that NAD administration had no obvious effects on myocardial Sirt5 and SDH-a expressions. However, the results of immunofluorescence showed that Sirt5 and SDH-a interacted in ischemia-reperfused myocardium. Utilizing co-immunoprecipitation method, we found that NAD administration promoted the Sirt5 and SDH-a interaction and decreased the succinylation level of SDH-a. These results implied that exogenous NAD administration promoted Sirt5-mediated SDH-a desuccinylation and decreased the activity of SDH-a, which attenuated the succinate accumulation during ischemia and its depleting rate during reperfusion and finally alleviated reactive oxygen species generation.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Myocardial ischemia-reperfusion; Nicotinamide adenine dinucleotide; Sirt5; Succinate; Succinate dehydrogenase

Year:  2019        PMID: 31278893     DOI: 10.1016/j.ejphar.2019.172520

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities.

Authors:  Mahmoud Abdellatif; Heiko Bugger; Guido Kroemer; Simon Sedej
Journal:  J Lipid Atheroscler       Date:  2022-04-06

Review 2.  The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential.

Authors:  Xiaokai Zhang; Yang Zhang; Aijun Sun; Junbo Ge
Journal:  Genes Dis       Date:  2021-04-24

Review 3.  Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.

Authors:  Ling He; Fuxiang Liu; Juxiang Li
Journal:  Cardiovasc Toxicol       Date:  2021-01-12       Impact factor: 3.231

4.  Visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis.

Authors:  Hai-Rong Fu; Xiao-Shan Li; Yong-Hui Zhang; Bin-Bin Feng; Lian-Hong Pan
Journal:  Eur J Histochem       Date:  2020-09-07       Impact factor: 3.188

Review 5.  Role of Oxidative DNA Damage and Repair in Atrial Fibrillation and Ischemic Heart Disease.

Authors:  Liangyu Hu; Zhengkun Wang; Claudia Carmone; Jaap Keijer; Deli Zhang
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

6.  Controlled power: how biology manages succinate-driven energy release.

Authors:  Shona A Mookerjee; Akos A Gerencser; Mark A Watson; Martin D Brand
Journal:  Biochem Soc Trans       Date:  2021-12-17       Impact factor: 5.407

Review 7.  Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases.

Authors:  Noemi Rotllan; Mercedes Camacho; Mireia Tondo; Elena M G Diarte-Añazco; Marina Canyelles; Karen Alejandra Méndez-Lara; Sonia Benitez; Núria Alonso; Didac Mauricio; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Josep Julve
Journal:  Antioxidants (Basel)       Date:  2021-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.